Xanadu Quantum reports hardware gains and revenue rise as losses widen in Q2
Xanadu Quantum Technologies (XNDU) posted a 43 per cent jump in quarterly revenue to $1.5 million, driven by improved fabrication throughput and continued government contracts, though adjusted EBITDA losses expanded to $21.3 million as the company ramps up engineering and manufacturing capabilities.
Xanadu Quantum Technologies (XNDU) reported significant hardware advancements in its second quarter of 2026, achieving an average edge-coupling loss of 0.085 dB per facet. The company stated this metric may be the lowest in the industry, representing a critical component-level improvement in photonic chip efficiency. This progress is supported by the firm’s internal advanced photonic chip-packaging facility and collaborations with Corning and DISCO for fibre arrays and wafer singulation.
To support this hardware roadmap, Xanadu increased fabrication throughput by 75 per cent for thin-film lithium niobate and 50 per cent for silicon nitride. The company is leveraging expanded capacity through WaferTech, a UMC subsidiary, and NY CREATES to run more parallel design and testing cycles. These efforts aim to reduce the aggregate optical-loss gap, which the firm notes has declined by up to 200 times over four years, though a further five to 10 times reduction remains necessary for scalable fault-tolerant operation.
Financially, revenue rose 43 per cent year-on-year to $1.5 million, although adjusted EBITDA losses widened to $21.3 million due to increased research and development spending. The higher losses reflect deliberate investments in engineering hiring, stock-based compensation, and capital expenditures for specialized testing equipment. Capital expenditures jumped to $6.4 million from $0.3 million in the first quarter, underscoring the company’s push to scale manufacturing infrastructure ahead of its expected Analyst Day update.
The company holds $312.8 million in cash and is awaiting potential updates on Project OPTIMISM, a government funding initiative that could provide up to C$390 million for photonic packaging and quantum-module assembly. Additionally, Xanadu is seeking advancement to Stage C of the DARPA Quantum Benchmarking Initiative, a milestone the company believes would provide independent validation of its fault-tolerance progress and strengthen its credibility with US government customers.
Valuation remains milestone-driven, with the stock trading at a market capitalisation of approximately $3.2 billion. Analysts view the upcoming detailed loss and hardware roadmap, expected around the end of summer, as a key catalyst for rerating. The company’s ability to translate its expanded capital base into faster optical-loss reduction and qubit-factory progress will be critical in determining whether the current discount to quantum peers narrows.
